Visit 0 week~Patients with subacute cough,area randomized to either ebastine/pseudoephedrine or placebo for 1 week.~The cough severity and quality of life were measure with VAS score and cough-specific quality-of-life questionnaire(CQLQ)~Visit 1 week check VAS score and CQLQ~Visit 4 weeks check VAS score and CQLQ
To determine whether ebastine/pseudoephedrine is effective on subacute cough.